Compounds > mci-196
Page last updated: 2024-08-24

mci-196 and Hyperlipoproteinemia Type II

mci-196 has been researched along with Hyperlipoproteinemia Type II in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inazu, A; Kawashiri, MA; Kobayashi, J; Mabuchi, H; Miyashita, K; Nakajima, K; Nohara, A; Tada, H; Yamagishi, M1
Miyamori, I; Suzuki, J; Takahashi, S; Zenimaru, Y1
Fujino, N; Hayashi, K; Inazu, A; Kawashiri, MA; Kobayashi, J; Konno, T; Mabuchi, H; Mori, M; Nakanishi, C; Noguchi, T; Nohara, A; Tada, H; Yamagishi, M1
Higashikata, T; Inazu, A; Kawashiri, MA; Kobayashi, J; Koizumi, J; Mabuchi, H; Nohara, A1
Homma, Y; Kobayashi, T; Nakamura, H; Ozawa, H; Sakane, H; Yamaguchi, H1

Trials

4 trial(s) available for mci-196 and Hyperlipoproteinemia Type II

ArticleYear
Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy.
    Lipids in health and disease, 2016, Apr-02, Volume: 15

    Topics: Adult; Aged; Anticholesteremic Agents; Drug Therapy, Combination; Epichlorohydrin; Ezetimibe; Female; Humans; Hyperlipoproteinemia Type II; Imidazoles; Lipase; Lipoprotein Lipase; Male; Middle Aged; Receptors, LDL; Resins, Synthetic; Rosuvastatin Calcium

2016
Efficacy and safety of coadministration of rosuvastatin, ezetimibe, and colestimide in heterozygous familial hypercholesterolemia.
    The American journal of cardiology, 2012, Feb-01, Volume: 109, Issue:3

    Topics: Aged; Aged, 80 and over; Anion Exchange Resins; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epichlorohydrin; Ezetimibe; Female; Fluorobenzenes; Follow-Up Studies; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Imidazoles; Male; Middle Aged; Prospective Studies; Pyrimidines; Resins, Synthetic; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome

2012
Efficacy of colestimide coadministered with atorvastatin in japanese patients with heterozygous familial hypercholesterolemia (FH).
    Circulation journal : official journal of the Japanese Circulation Society, 2005, Volume: 69, Issue:5

    Topics: Anion Exchange Resins; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Drug Therapy, Combination; Epichlorohydrin; Female; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Imidazoles; Japan; Male; Middle Aged; Pyrroles; Resins, Synthetic

2005
Specific reduction of plasma large, light low-density lipoprotein by a bile acid sequestering resin, cholebine (MCI-196) in type II hyperlipoproteinemia.
    Atherosclerosis, 1997, Mar-21, Volume: 129, Issue:2

    Topics: Anticholesteremic Agents; Apolipoproteins; Bile Acids and Salts; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol, LDL; Glycoproteins; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Lipoproteins, IDL; Lipoproteins, LDL; Molecular Weight; Phosphatidylcholine-Sterol O-Acyltransferase; Receptors, LDL; Triglycerides

1997

Other Studies

1 other study(ies) available for mci-196 and Hyperlipoproteinemia Type II

ArticleYear
[A case of type 2 diabetes mellitus associated with familial hypercholesterolemia confirming the improvement of blood glucose control by colestimide].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2009, Volume: 46, Issue:6

    Topics: Aged; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Humans; Hyperlipoproteinemia Type II; Imidazoles; Resins, Synthetic

2009